Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis c
Comorbidity C0011847|diabetes
Sentences 25
PubMedID- 20040053 Aim: the aim of this study was to investigate an association between antidiabetic therapies and the incidence of hcc in hepatitis c patients with diabetes mellitus.
PubMedID- 22014257 Multiple co-morbidities including diabetes (23% of patients), hypertension (36%), hepatitis c (43%), and depression (74%) were concurrently managed.
PubMedID- 22245505 We compared incidence of liver-related events and mortality rates between hepatitis c virus-positive patients with or without diabetes mellitus, and the incidence of diabetes-related events between diabetic patients with and without hepatitis c.
PubMedID- 22497813 During the first nhanes cycle (1988-1994), insulin and diabetes were independently associated with hepatitis c.
PubMedID- 23049551 Association of hepatitis c virus infection with type ii diabetes in ethiopia: a hospital-based case-control study.
PubMedID- 20666689 Nafld/nash and type 2 diabetes mellitus, along with hepatitis c virus infection, were the major etiologic risk factors associated with hcc.
PubMedID- 22701277 diabetes in patients with chronic hepatitis c infection (chc) has unique and complex pathogenesis, which distinguishes this metabolic disorder from type 2 diabetes mellitus.
PubMedID- 24904670 Berberine also effectively lowered fasting plasma glucose in chronic hepatitis b and hepatitis c patients with type 2 diabetes mellitus.
PubMedID- 20558353 The early recurrence, viremia and more severe fibrosis after antiviral therapy have an impact on the occurrence of new-onset diabetes in hepatitis c positive patients.
PubMedID- 20688613 Sitagliptin in treatment of diabetes complicated by chronic hepatitis c.
PubMedID- 21110426 4) the distribution of hcv genotypes in chronic hepatitis c patients with and without diabetes mellitus is not significantly different.
PubMedID- 24500979 Relationship of hepatitis c virus infection with diabetes in the u.s.
PubMedID- 22014765 Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis c.
PubMedID- 22218030 Moreover, this risk escalates if diabetes coincides with chronic hepatitis c and cirrhosis.
PubMedID- 24353540 Most cross-sectional studies comparing the prevalence of diabetes in patients with chronic hepatitis c with that of a comparator group have shown that patients infected with hcv present with diabetes more often than patients with chronic liver diseases of other etiologies, even at a pre-cirrhotic stage.15 this observation was confirmed by a vast general population-based survey and by several longitudinal studies.16 most of the risk affects patients with other cofactors of diabetes, suggesting that hcv infection may significantly increase the rate of developing glucose metabolism alterations in predisposed individuals.
PubMedID- 20521408 Results: the study included 1,283 subjects, 69.0% male, 39.7% injecting drug users, 19.5% hepatitis c infected, 6.5% with diabetes mellitus (dm-2), 11.6% had hypertension (htn) and 9.0% had kidney disease.
PubMedID- 22089377 Occurrence of diabetes was not associated with hiv-related markers, hepatitis c, hypertension or family history of diabetes.
PubMedID- 22418268 Insulin resistance and diabetes mellitus in patients with chronic hepatitis c: spectators or actors.
PubMedID- 24523328 When planning therapeutic interventions in chronic hepatitis c in patients with diabetes, it is considered the presence of visceral obesit , dyslipidemia, and hepatic steatosis.
PubMedID- 21270202 Chronic hepatitis c is strongly associated with type 2 diabetes (7), whereas the occurrence of type 1 diabetes in chronic hepatitis c is almost always associated with the use of interferon (2–4).
PubMedID- 22310786 Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis c virus infection after renal transplantation.
PubMedID- PMC4034027 Ifnα has been reported to induce symptoms of insulin-dependent type i diabetes in patients with chronic hepatitis c infection; for the most part in individuals with pre-existing autoimmunity and/or with a genetic predisposition [45,92].
PubMedID- 22676360 Although hepatitis c (hcv) is associated with diabetes, few studies have examined pre-diabetes in this population.
PubMedID- 21645344 Several additional studies have also assessed the prevalence of type 2 diabetes mellitus in patients with chronic hepatitis c infection, affecting between 8 and 25% of these patients [21,22].
PubMedID- 23909647 Pre-existing hypertension, obesity, and diabetes increased the risk of dyslipidemia, whereas hepatitis c virus, lower cd4(+) t cell count, and higher hiv viral load had a protective effect.

Page: 1